Ignite Creation Date:
2024-07-17 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06494241
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
SmallMiddle Tier Cities and County Lung Cancer Quality Improvement Project QIP Study
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in SmallMiddle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the molecular testing pattern in metastatic NSCLC patients after QIP To evaluate the treatment pattern in metastatic NSCLC patients after QIP
Detailed Description:
The primary objective of this study is to assess the implementation of standardized diagnosis and treatment practice in oncology departments of SmallMiddle tier cities and County hospitals after standardized education and implementation of lung cancer clinical practice guidelines for oncology physicians
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None